- Home
- OKYO vs RFM Comparison
OKYO vs RFM Comparison
Compare OKYO & RFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OKYO
- RFM
- Stock Information
- Founded
- OKYO 2007
- RFM 2020
- Country
- OKYO United Kingdom
- RFM United States
- Employees
- OKYO N/A
- RFM N/A
- Industry
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- RFM Finance/Investors Services
- Sector
- OKYO Health Care
- RFM Finance
- Exchange
- OKYO Nasdaq
- RFM Nasdaq
- Market Cap
- OKYO 95.3M
- RFM 85.5M
- IPO Year
- OKYO 2022
- RFM N/A
- Fundamental
- Price
- OKYO $3.18
- RFM $13.92
- Analyst Decision
- OKYO Strong Buy
- RFM
- Analyst Count
- OKYO 1
- RFM 0
- Target Price
- OKYO $7.00
- RFM N/A
- AVG Volume (30 Days)
- OKYO 186.1K
- RFM 20.7K
- Earning Date
- OKYO 08-12-2025
- RFM 01-01-0001
- Dividend Yield
- OKYO N/A
- RFM 9.74%
- EPS Growth
- OKYO N/A
- RFM N/A
- EPS
- OKYO N/A
- RFM N/A
- Revenue
- OKYO N/A
- RFM N/A
- Revenue This Year
- OKYO N/A
- RFM N/A
- Revenue Next Year
- OKYO N/A
- RFM N/A
- P/E Ratio
- OKYO N/A
- RFM N/A
- Revenue Growth
- OKYO N/A
- RFM N/A
- 52 Week Low
- OKYO $0.81
- RFM $12.89
- 52 Week High
- OKYO $3.15
- RFM $16.41
- Technical
- Relative Strength Index (RSI)
- OKYO 63.19
- RFM 47.99
- Support Level
- OKYO $2.46
- RFM $13.95
- Resistance Level
- OKYO $2.85
- RFM $13.98
- Average True Range (ATR)
- OKYO 0.25
- RFM 0.12
- MACD
- OKYO -0.02
- RFM 0.01
- Stochastic Oscillator
- OKYO 92.75
- RFM 40.70
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
About RFM RiverNorth Flexible Municipal Income Fund Inc.
RiverNorth Flexible Municipal Income Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.